NIA Archive — Page 1 of 4
-
September 22, 2022
Reduced exercise capacity in ICU survivors
ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose. -
June 6, 2022
Tracking the aging brain
The macrostructure — volume, area and length — of the brain’s white matter is useful for studying aging and could be a sensitive marker for neurodegenerative disorders such as Alzheimer’s disease, Vanderbilt researchers reported. -
February 24, 2022
PET imaging probe for Alzheimer’s disease
Vanderbilt researchers report on a new PET imaging probe that will be useful for exploring Alzheimer’s disease pathology. -
January 18, 2022
Ensuring the “best possible” medication history
About 80% of hospital admission electronic records were missing a drug prescribed to an older adult, Vanderbilt researchers found, highlighting the need for a multipronged approach to address medication discrepancies and support safe prescribing practices. -
October 28, 2021
Pancreatic beta-cell booster
Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications. -
October 21, 2021
Study links genetic variants, protein expression and human diseases
An international research team has developed a new resource that connects genetic variants and protein expression, which is expected to speed the identification of genes that cause disease — and point to novel treatment strategies. -
August 23, 2021
Estrogen, depression and menopause
A shift in emotional processing may help women adapt to lower estrogen after menopause —unless they have a history of major depressive disorder, Vanderbilt researchers have found.